Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 18, Number 11—November 2012
Research

Epidemic Myalgia in Adults Associated with Human Parechovirus Type 3 Infection, Yamagata, Japan, 2008

Katsumi MizutaComments to Author , Makoto Kuroda, Masayuki Kurimura, Yoshikazu Yahata, Tsuyoshi Sekizuka, Yoko Aoki, Tatsuya Ikeda, Chieko Abiko, Masahiro Noda, Hirokazu Kimura, Tetsuya Mizutani1, Takeo Kato, Toru Kawanami, and Tadayuki Ahiko
Author affiliations: Yamagata Prefectural Institute of Public Health, Yamagata, Japan (K. Mizuta, Y. Aoki, T. Ikeda, C. Abiko, T. Ahiko); National Institute of Infectious Diseases, Tokyo, Japan (M. Kuroda, T. Sekizuka, M. Noda, H. Kimura, T. Mizutani); Yonezawa City Hospital, Yamagata (M. Kurimura, Y. Yahata); and Yamagata University Faculty of Medicine, Yamagata (T. Kato, T. Kawanami)

Main Article

Table 2

Primers used to detect and sequence analysis for human parechovirus 3 among patients with epidemic myalgia, Yonezawa, Yamagata, Japan, June–August 2008

Primer Nucleotide sequence, 5′ → 3′ Nucleotide position*
Parecho3-F2K AACAAGTGACACTATGGATCTGATC 576–601
Parecho3-F3K CAAAGTAGCAGATGATGCTTCCAA 824–849
Parecho3-F4K CAAGCCAAATATTTTGCTGCAGTAA 1165–1190
Parecho3-F5K TGCATTGGTGGTTTATGAGCCTAA 1244–1268
Parecho3-F21K TCAGACAACACCACACCTTCAAG 1822–1844
Parecho3-VP1F1Y GGGCCTTTGGGTAATGAGAAA 2452–2472
Parecho3-VP1F2Y TGACAACATATTTGGTAGAGCTTGGT 2538–2563
Parecho3-F6K AGGAGATAATGTATATCAATTGGAT 3095–3120
Parecho3-F7K TGACGGCTGGTTTAATGTCAACTAT 3368–3392
Parecho3-F8K CTGAATCAATGTCCAACACAGACGA 3737–3761
Parecho3-F9K TGGACTATGCCTCTGATATTATTGT 3994–4019
Parecho3-F10K AATAATGGCCATTTGCTTTAGGAGT 4098–4122
Parecho3-F11K CTTGTAAATTAAATGGTGTGTACAC 4304–4328
Parecho3-F12K ACTAGGAAGGAGAAAGATATTGAAA 4402–4426
Parecho3-F13K CAGCCAAAGCATATAGTAGGGCTG 4609–4633
Parecho3-F14K TTGAACAAATGGAAGCCTTCATTGA 4916–4940
Parecho3-F15K GTTGTAGACTGGTTCAGTAGTAAG 5011–5034
Parecho3-F16K AAAGGAACTTTCCCAGTCACGCAGA 5201–5225
Parecho3-F17K CAGAGAGTATGTTGATTTGGATGAC 5553–5576
Parecho3-F18K GTGGCTATTCCTTTCAATTTTCTT 5778–5802
Parecho3-F19K GGCCCAGCAGTTTTAAGCAAATCAG 5863–5947
Parecho3-F20K TTGTCATGATTCACCTGATCTTGTC 6608–6633
Parecho3-R13K AGTTTGTGGTATTTACAGTGGTTGT 912–938
Parecho3-R11K TTTTAACGTAGTTTGTGTCTGCA 1380–1402
Parecho3-R15 CATGTATAGAATATGAATGTTTATT 2673–2697
Parecho3-VP1R2Y ACCCCTGCTCTGCCATGTATA 2693–2710
Parecho3-VP1R1Y TCCCGTGCATCATTGGTCTA 2883–2902
Parecho3-R10K TGACAGATGATTCAAGATACTTCAC 3238–3253
Parecho3-R9K AGTGGTACACTTCTGCACAAGTAAG 3468–3492
Parecho3-R8K ATCCACCAATCAATATGTCTGAATG 3859–3884
Parecho3-R7K TGGATAGTGTGTGTGTTAGGAAAGA 4264–4288
Parecho3-R5K CCACTTTAGAAATAAGCAGACCACC 5701–5725
Parecho3-R4K CCATTTTGACTTCCACTGCTCCA 5901–5923
Parecho3-R3K CCTAAATTTGGACTTGACACAGG 5993–6015
HPeV3whole-RT-RK TTTTGGTATGTCCAATATTCCAAATTAGTG 7296–7321

*Relative to human parechovirus 3 strain A308/99 (GenBank accession no. AB084913).

Main Article

1Current affiliation: Tokyo University of Agriculture and Technology Research and Education Center for Prevention of Global Infectious Diseases of Animals, Tokyo, Japan.

Page created: October 15, 2012
Page updated: October 15, 2012
Page reviewed: October 15, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external